Leroux-Roels G - Search Results

1

Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine.

Vandepapelière P, Lau GK, Leroux-Roels G, Horsmans Y, Gane E, Tawandee T, Merican MI, Win KM, Trepo C, Cooksley G, Wettendorff M, Ferrari C; Therapeutic HBV Vaccine Group of Investigators. Vandepapelière P, et al. Vaccine. 2007 Dec 12;25(51):8585-97. doi: 10.1016/j.vaccine.2007.09.072. Epub 2007 Oct 24. Vaccine. 2007. PMID: 18031872 Clinical Trial.

2

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

Leroux-Roels G, Van Hecke E, Michielsen W, Voet P, Hauser P, Pêtre J. Leroux-Roels G, et al. Vaccine. 1994 Jul;12(9):812-8. doi: 10.1016/0264-410x(94)90290-9. Vaccine. 1994. PMID: 7975860 Clinical Trial.

3

Haptoglobin polymorphism and the immune response after hepatitis B vaccination.

Louagie H, Delanghe J, Desombere I, De Buyzere M, Hauser P, Leroux-Roels G. Louagie H, et al. Vaccine. 1993 Sep;11(12):1188-90. doi: 10.1016/0264-410x(93)90041-u. Vaccine. 1993. PMID: 8256500 Clinical Trial.

4

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

Leroux-Roels G, Desombere I, De Tollenaere G, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Vaccine. 1997 Nov;15(16):1724-31. doi: 10.1016/s0264-410x(97)00117-5. Vaccine. 1997. PMID: 9364674 Clinical Trial.

5

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Vaccine. 1997 Nov;15(16):1732-6. doi: 10.1016/s0264-410x(97)00118-7. Vaccine. 1997. PMID: 9364675 Clinical Trial.

6

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system.

Thoelen S, Van Damme P, Mathei C, Leroux-Roels G, Desombere I, Safary A, Vandepapeliere P, Slaoui M, Meheus A. Thoelen S, et al. Vaccine. 1998 Apr;16(7):708-14. doi: 10.1016/s0264-410x(97)00254-5. Vaccine. 1998. PMID: 9562690 Clinical Trial.

7

The first combined vaccine against hepatitis A and B: an overview.

Thoelen S, Van Damme P, Leentvaar-Kuypers A, Leroux-Roels G, Bruguera M, Frei PC, Bakasenas V, Safary A. Thoelen S, et al. Vaccine. 1999 Mar 26;17(13-14):1657-62. doi: 10.1016/s0264-410x(98)00421-6. Vaccine. 1999. PMID: 10194819

8

A hepatitis B vaccine formulated with a novel adjuvant system.

Ambrosch F, Wiedermann G, Kundi M, Leroux-Roels G, Desombere I, Garcon N, Thiriart C, Slaoui M, Thoelen S. Ambrosch F, et al. Vaccine. 2000 Apr 14;18(20):2095-101. doi: 10.1016/s0264-410x(99)00566-6. Vaccine. 2000. PMID: 10715523 Clinical Trial.

9

A comparison of two commercial recombinant vaccines for hepatitis B in adolescents.

Leroux-Roels G, Abraham B, Fourneau M, De Clercq N, Safary A. Leroux-Roels G, et al. Vaccine. 2000 Nov 22;19(7-8):937-42. doi: 10.1016/s0264-410x(00)00217-6. Vaccine. 2000. PMID: 11115719 Clinical Trial.

10

The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population.

Jacques P, Moens G, Desombere I, Dewijngaert J, Leroux-Roels G, Wettendorff M, Thoelen S. Jacques P, et al. Vaccine. 2002 Nov 1;20(31-32):3644-9. doi: 10.1016/s0264-410x(02)00397-3. Vaccine. 2002. PMID: 12399191 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters